Liver Cirrhosis, Biliary
21
0
0
12
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
28.6%
6 terminated out of 21 trials
66.7%
-19.8% vs benchmark
24%
5 trials in Phase 3/4
42%
5 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (21)
Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women
Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia
Study of INT 747 in Combination With URSO in Patients With Primay Biliary Cirrhosis (PBC)
Phase 4 Study of Obeticholic Acid Evaluating Clinical Outcomes in Patients With Primary Biliary Cholangitis
BRIDGE Device for Post-operative Pain Control
Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment
Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome
Study of INT-747 as Monotherapy in Participants With Primary Biliary Cirrhosis (PBC)
Physical Therapy for Liver Cirrhosis
Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China Hospital
Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis
SAMe to Treat Biliary Cirrhosis Symptoms
Pilot Study of Budesonide for Patients With Primary Sclerosing Cholangitis
Pharmacokinetic Study Of Tigecycline In Adult Subjects With Primary Biliary Cirrhosis
Treatment of Cholestatic Pruritus With Sertraline
Ursodiol-Methotrexate for Primary Biliary Cirrhosis
Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis
Identification of the Genetic Variants Responsible for Primary Biliary Cirrhosis (PBC)
Low-Dose Oral Methotrexate Versus Colchicine for Primary Biliary Cirrhosis